查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492670

Ciclanderate 市場：按配方、應用、分銷管道分類 - 全球預測 2024-2030

Cyclandelate Market by Formulation (Injectable, Oral), Application (Cerebral Vascular Insufficiency, Peripheral Vascular Disorder), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年Ciclanderate市場規模為6.4674億美元，預計2024年將達到6.7733億美元，2030年將達到9.0449億美元，複合年成長率為4.90%。

西克蘭德酯是一種主要用於治療與血液循環不良相關的疾病的藥物。西蘭酸可以放鬆血管平滑肌，增加血流。透過擴張血管，可以緩解與血管疾病相關的症狀，如痙攣、疼痛、手腳冰冷等。西克蘭德酯通常口服，其使用和劑量應在醫療保健專業人員的指導下進行。由於生活習慣和人口老化，與血液循環不良相關的疾病不斷增加，對香菜酸等有效治療藥物的需求不斷增加。改善醫療基礎設施和增加醫療成本可能會導致人們廣泛獲得和採用包括香菜在內的治療方法。然而，嚴格的藥物核准和市場准入法規可能會造成重大障礙，延長開發時間並增加成本。此外，藥物研究和開發的進步可能會擴大香菜酯的用途或提高其功效和安全性，從而促進市場成長。藥物傳遞方面的創新，例如控制釋放製劑，有可能改善患者的治療效果和對含環化合物治療的依從性。

主要市場統計
基準年[2023] 64674萬美元
預測年份 [2024] 67733萬美元
預測年份 [2030] 90449萬美元
複合年成長率（%） 4.90%

區域洞察

在美國和加拿大，香菜的消費很大程度上與人們對周圍血管疾病的認知增強和人口老化同時發生。這些因素導致了對有效的血管擴張劑治療的需求，例如西蘭德酯，以緩解腦血管供血不足和周邊動脈疾病等症狀。該地區的客戶行為反映了對受臨床研究支持並獲得美國FDA 等監管機構核准的產品的偏好。歐盟國家擁有強大的醫療保健和藥品監管體系，由歐洲藥品管理局 (EMA) 和其他機構管理。該地區老年人口普遍較多，醫藥產業發展完善，注重藥品安全性和有效性，因此對香菜的需求穩定。中東和非洲地區是一個醫療保健系統多樣化的市場。高所得國家已經建立了與西方標準相當的衛生系統，包括獲得含有香菜酸鹽的藥物。然而，在非洲部分地區，經濟限制和後勤挑戰可能限制獲得基本藥物。亞太地區是一個經濟和醫療保健領域快速成長的地區。中國和印度正在對醫療基礎設施和當地藥品生產進行大量投資，降低藥品價格，讓更多人更容易獲得藥品。日本以其先進的研究能力而聞名，不斷探索新的治療可能性和環己烷等藥物的輸送系統。

FPNV定位矩陣

FPNV 定位矩陣對於評估 Ciclanderate 市場中的供應商定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 Ciclanderate 市場供應商的當前狀態進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在 Ciclanderate 市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球週邊血管疾病盛行率增加
      • 改善投資以加強醫療基礎設施
    • 抑制因素
      • 原料成本波動
    • 機會
      • 藥物輸送系統的創新和環烷酸鹽改進配方的開發
      • 政府核准生產和銷售香薺菜
    • 任務
      • 替代藥物的可用性和與西蘭德酯相關的副作用
  • 市場區隔分析
    • 劑型：由於劑量控制和即時治療效果，注射用環烷酸鹽變得越來越重要
    • 分銷管道：醫院藥房可提供即時獲取，在急診環境中至關重要。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 西蘭德市場：依配方分類

  • 注射
  • 口服

第7章 西蘭德市場：依應用分類

  • 腦血管供血不足
  • 週邊血管疾病

第 8 章 Ciklanderat 市場：按分銷管道

  • 醫院藥房
  • 網路藥房

第9章 美洲的環烷酸鹽市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太Ciclanderat市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲西蘭德市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭場景分析
    • 加拿大政府宣布投資 2,600 萬加元加強綜合衛生系統
    • 政府對印度製藥和醫療設備產業的大量投資
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5D693B46C72B

[194 Pages Report] The Cyclandelate Market size was estimated at USD 646.74 million in 2023 and expected to reach USD 677.33 million in 2024, at a CAGR 4.90% to reach USD 904.49 million by 2030.

Cyclandelate is a medication mainly used to treat conditions related to poor blood circulation. Cyclandelate relaxes smooth muscles in blood vessels, which can help to increase blood flow. This widening of blood vessels can alleviate symptoms associated with vascular disorders, such as cramps, pain, and feeling cold in the limbs. Cyclandelate is typically taken orally, and its usage and dosage should be guided by a healthcare professional's advice. Increasing incidences of diseases related to poor blood circulation due to lifestyle factors and an aging population drive demand for effective treatments such as Cyclandelate. Enhanced healthcare infrastructure and increased healthcare spending can lead to broader accessibility and adoption of treatments involving Cyclandelate. However, stringent regulations in drug approval and market entry for pharmaceuticals can pose a significant barrier, extending development timelines and increasing costs. Furthermore, advances in pharmaceutical R&D may expand the applications of Cyclandelate or improve its efficacy and safety profile, contributing to market growth. Innovations in medication deliveries, such as controlled-release formulations, could improve patient outcomes and adherence to therapy involving Cyclandelate.

KEY MARKET STATISTICS
Base Year [2023] USD 646.74 million
Estimated Year [2024] USD 677.33 million
Forecast Year [2030] USD 904.49 million
CAGR (%) 4.90%

Regional Insights

In the United States and Canada, the consumption of cyclandelate largely aligns with the increasing awareness of peripheral vascular diseases and the aging population. These factors contribute to the demand for effective vasodilatory treatments, such as cyclandelate, which helps alleviate conditions such as cerebral vascular insufficiency and peripheral artery disease. Customer behavior in this region reflects a preference for products that are endorsed by clinical research and approved by regulatory bodies like the FDA in the USA. EU countries exhibit a strong system for healthcare and medication regulation, managed by entities including the European Medicines Agency (EMA). The region has a consistent demand for cyclandelate, driven by a generally older population and a well-established pharmaceutical sector emphasizing drug safety and efficacy. The MEA region presents a diverse market with varying access to healthcare systems. Higher-income countries have well-established healthcare systems comparable to Western standards, including access to medications, including cyclandelate. However, in parts of Africa, access to essential medications can be limited by economic constraints and logistical challenges. Asia Pacific is a rapidly growing region in terms of both economy and healthcare advancements. China and India are investing significantly in healthcare infrastructure and local pharmaceutical manufacturing, driving down the cost of medication and making it more accessible to the wider population. Japan, known for its advanced research capabilities, continues to explore new therapeutic potentials and delivery systems for drugs such as cyclandelate.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cyclandelate Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of peripheral vascular diseases worldwide
      • Improved investments for enhancing healthcare infrastructures
    • Market Restraints
      • Fluctuation in costs of raw materials
    • Market Opportunities
      • Innovation in drug delivery systems and development of improved formulations of cyclandelate
      • Government approvals for production and marketing of cyclandelate
    • Market Challenges
      • Availability of alternative drugs and side effects associated with cyclandelate
  • Market Segmentation Analysis
    • Formulation: Growing significance of injectable cyclandelate due to controlled dosages and immediate therapeutic effects
    • Distribution Channel: Hospital pharmacies essential for immediate access and crucial for acute care settings
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cyclandelate Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cyclandelate Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Government of Canada Announces CAD 26 Million Investment to Enhance Integrated Health Care Systems

The Government of Canada, in collaboration with several partners, announced a significant investment exceeding CAD 26 million aimed at improving integrated healthcare services across the nation. This funding supports initiatives designed to streamline healthcare delivery, fostering more coordinated and patient-centered services. This investment aims to enhance efficiency in healthcare systems and targets the improvement of patient outcomes, focusing on seamless integration between different healthcare providers to ensure that Canadians receive timely and effective care. [Published On: 2023-10-20]

Significant Government Investment in India's Pharma and Medical Device Sectors

The Indian government has approved a substantial investment of INR 6,000 crore under the Production Linked Incentive (PLI) scheme aimed at bolstering the pharmaceutical and medical devices sectors, as announced by the Home Minister. This strategic move is designed to enhance self-reliance in critical healthcare segments by incentivizing domestic production, reducing import dependencies, and accelerating the development of high-quality medical products. [Published On: 2023-09-30]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cyclandelate Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cyclandelate Market, highlighting leading vendors and their innovative profiles. These include Biosynth, Chemwill Asia co.,Ltd, Jinan Jinda Pharmaceutical Chemistry Co.,Ltd, LGC Limited, Merck KGaA, RayBiotech, Inc., SAGECHEM, Taj Pharmaceuticals Limited, Tebubio, Thermo Fisher Scientific Inc., Tokyo Chemical Industry, and Vial Health Technology, Inc..

Market Segmentation & Coverage

This research report categorizes the Cyclandelate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Injectable
    • Oral
  • Application
    • Cerebral Vascular Insufficiency
    • Peripheral Vascular Disorder
  • Distribution Channel
    • Hospitals Pharmacies
    • Online Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of peripheral vascular diseases worldwide
      • 5.1.1.2. Improved investments for enhancing healthcare infrastructures
    • 5.1.2. Restraints
      • 5.1.2.1. Fluctuation in costs of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation in drug delivery systems and development of improved formulations of cyclandelate
      • 5.1.3.2. Government approvals for production and marketing of cyclandelate
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative drugs and side effects associated with cyclandelate
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Growing significance of injectable cyclandelate due to controlled dosages and immediate therapeutic effects
    • 5.2.2. Distribution Channel: Hospital pharmacies essential for immediate access and crucial for acute care settings
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cyclandelate Market, by Formulation

  • 6.1. Introduction
  • 6.2. Injectable
  • 6.3. Oral

7. Cyclandelate Market, by Application

  • 7.1. Introduction
  • 7.2. Cerebral Vascular Insufficiency
  • 7.3. Peripheral Vascular Disorder

8. Cyclandelate Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospitals Pharmacies
  • 8.3. Online Pharmacies

9. Americas Cyclandelate Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cyclandelate Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cyclandelate Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Government of Canada Announces CAD 26 Million Investment to Enhance Integrated Health Care Systems
    • 12.3.2. Significant Government Investment in India's Pharma and Medical Device Sectors
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CYCLANDELATE MARKET RESEARCH PROCESS
  • FIGURE 2. CYCLANDELATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CYCLANDELATE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CYCLANDELATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CYCLANDELATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CYCLANDELATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CYCLANDELATE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CYCLANDELATE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CYCLANDELATE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CYCLANDELATE MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CYCLANDELATE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR INSUFFICIENCY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CYCLANDELATE MARKET SIZE, BY CEREBRAL VASCULAR INSUFFICIENCY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISORDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CYCLANDELATE MARKET SIZE, BY PERIPHERAL VASCULAR DISORDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CYCLANDELATE MARKET SIZE, BY HOSPITALS PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CYCLANDELATE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 39. BRAZIL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 40. BRAZIL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. CANADA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. CANADA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES CYCLANDELATE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 74. AUSTRALIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. CHINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 80. CHINA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. INDIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. INDIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. INDONESIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDONESIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. JAPAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 98. JAPAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. MALAYSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 110. PHILIPPINES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 116. SINGAPORE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 122. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. TAIWAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. TAIWAN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. THAILAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 134. THAILAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. VIETNAM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 140. VIETNAM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CYCLANDELATE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. DENMARK CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 154. DENMARK CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. EGYPT CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. EGYPT CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. FINLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. FINLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. FRANCE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 172. FRANCE CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. GERMANY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. GERMANY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. ISRAEL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 184. ISRAEL CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. ITALY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 190. ITALY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 196. NETHERLANDS CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. NIGERIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. NIGERIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. NORWAY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 208. NORWAY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. POLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 214. POLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 219. QATAR CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 220. QATAR CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. RUSSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 226. RUSSIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. SPAIN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 244. SPAIN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. SWEDEN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 250. SWEDEN CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWITZERLAND CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 261. TURKEY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 262. TURKEY CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CYCLANDELATE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. CYCLANDELATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. CYCLANDELATE MARKET, FPNV POSITIONING MATRIX, 2023